iHuman Statistics
Total Valuation
iHuman has a market cap or net worth of $88.17 million. The enterprise value is -$73.50 million.
Important Dates
The last earnings date was Tuesday, March 31, 2026, before market open.
| Earnings Date | Mar 31, 2026 |
| Ex-Dividend Date | Apr 17, 2026 |
Share Statistics
iHuman has 51.11 million shares outstanding. The number of shares has decreased by -1.32% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 51.11M |
| Shares Change (YoY) | -1.32% |
| Shares Change (QoQ) | -0.24% |
| Owned by Insiders (%) | 72.39% |
| Owned by Institutions (%) | 0.35% |
| Float | 14.11M |
Valuation Ratios
The trailing PE ratio is 6.69.
| PE Ratio | 6.69 |
| Forward PE | n/a |
| PS Ratio | 0.78 |
| Forward PS | n/a |
| PB Ratio | 0.62 |
| P/TBV Ratio | 0.64 |
| P/FCF Ratio | 13.16 |
| P/OCF Ratio | 12.19 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.57, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.57 |
| Quick Ratio | 3.30 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.12 |
| Debt / FCF | 0.24 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 9.75% and return on invested capital (ROIC) is 4.21%.
| Return on Equity (ROE) | 9.75% |
| Return on Assets (ROA) | 2.99% |
| Return on Invested Capital (ROIC) | 4.21% |
| Return on Capital Employed (ROCE) | 6.65% |
| Weighted Average Cost of Capital (WACC) | 4.88% |
| Revenue Per Employee | $159,586 |
| Profits Per Employee | $18,866 |
| Employee Count | 723 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 11.56 |
Taxes
In the past 12 months, iHuman has paid $913,159 in taxes.
| Income Tax | 913,159 |
| Effective Tax Rate | 6.27% |
Stock Price Statistics
The stock price has decreased by -24.23% in the last 52 weeks. The beta is 0.13, so iHuman's price volatility has been lower than the market average.
| Beta (5Y) | 0.13 |
| 52-Week Price Change | -24.23% |
| 50-Day Moving Average | 1.76 |
| 200-Day Moving Average | 2.35 |
| Relative Strength Index (RSI) | 48.24 |
| Average Volume (20 Days) | 9,917 |
Short Selling Information
The latest short interest is 7,876, so 0.05% of the outstanding shares have been sold short.
| Short Interest | 7,876 |
| Short Previous Month | 1,876 |
| Short % of Shares Out | 0.05% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.64 |
Income Statement
In the last 12 months, iHuman had revenue of $115.38 million and earned $13.64 million in profits. Earnings per share was $0.26.
| Revenue | 115.38M |
| Gross Profit | 78.29M |
| Operating Income | 9.54M |
| Pretax Income | 14.55M |
| Net Income | 13.64M |
| EBITDA | 10.65M |
| EBIT | 9.54M |
| Earnings Per Share (EPS) | $0.26 |
Full Income StatementBalance Sheet
The company has $164.58 million in cash and $1.63 million in debt, with a net cash position of $162.95 million or $3.19 per share.
| Cash & Cash Equivalents | 164.58M |
| Total Debt | 1.63M |
| Net Cash | 162.95M |
| Net Cash Per Share | $3.19 |
| Equity (Book Value) | 142.28M |
| Book Value Per Share | 2.78 |
| Working Capital | 133.59M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $7.34 million and capital expenditures -$700,989, giving a free cash flow of $6.80 million.
| Operating Cash Flow | 7.34M |
| Capital Expenditures | -700,989 |
| Depreciation & Amortization | 1.13M |
| Net Borrowing | n/a |
| Free Cash Flow | 6.80M |
| FCF Per Share | $0.13 |
Full Cash Flow StatementMargins
Gross margin is 67.86%, with operating and profit margins of 8.27% and 11.82%.
| Gross Margin | 67.86% |
| Operating Margin | 8.27% |
| Pretax Margin | 12.61% |
| Profit Margin | 11.82% |
| EBITDA Margin | 9.23% |
| EBIT Margin | 8.27% |
| FCF Margin | 5.89% |
Dividends & Yields
This stock pays an annual dividend of $0.10, which amounts to a dividend yield of 5.80%.
| Dividend Per Share | $0.10 |
| Dividend Yield | 5.80% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 2 |
| Payout Ratio | 33.03% |
| Buyback Yield | 1.32% |
| Shareholder Yield | 7.14% |
| Earnings Yield | 15.25% |
| FCF Yield | 7.60% |
Dividend DetailsAnalyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
iHuman has an Altman Z-Score of 3.07 and a Piotroski F-Score of 4.
| Altman Z-Score | 3.07 |
| Piotroski F-Score | 4 |
